Relevance to NICE guidance programmes
NICE has issued the following guidance which is relevant to this briefing:
-
Omalizumab for the treatment of severe persistent allergic asthma (review of TA133 and TA201). NICE technology appraisal guidance 278 (2013)
-
Bronchial thermoplasty for severe asthma. NICE interventional procedure guidance 419 (2012)